Mark McGowan, page-102

Sounds like McGowan has been listening to the Pfizer CEO who recently said

“We know that the two doses of the vaccine offer very limited protection, if any,” he said. “The three doses, with the booster, they offer reasonable protection against hospitalization and deaths. Against deaths, I think very good, and less protection against infection.”

Listen to the guy who is selling the vaccines for enormous profit.

Get a booster of the same formula which apparently doesn't work at two doses against Omicron. By the time everyone eligible is boosted with various waning rates to keep their jobs, Pfizer will release a new vaccine which is much more effective against Omicron which may not even be the dominant variant at that stage.

In the meantime WHO warning about too many boosters.

There are alternative strategies to keep hospitalizations lower that have been censored. Surely worth a try?


· Mexico City – The IMSSS Health Agency compared over 50,000 patients treated early with ivermectin to over 70,000 not treated and found up to a 75% reduction in need for hospitalization.
· La Misiones, Argentina – Health Ministry analyzed the data from 4,000 ivermectin treated patients and, compared to the rest of the population over the same time period, found a 75% reduction in need for hospital and an 88% reduction in death.
· Uttar Pradesh, India – Using a strategy of close surveillance combined with both ivermectin treatment of all positive cases and preventive treatment of all family contacts. On September 10, 2021, only 11 cases with no deaths were recorded in a population of 241 million..with 67 of their 75 districts having no active cases at the time.
· The Brazilian city of Itajai offerred ivermectin as prevention to the entire city’s population with 133,051 (60%) agreeing to take ivermectin every two weeks for 6 months. Compared to the 45,716 city inhabitants that declined to use ivermectin, ivermectin users were 47% less likely to contract illness, had a 70% lower mortality rate, and a 67% lower hospitalization rate. By the end of the 6 month program, the citywide COVID mortality fell from 6.8% to 1.8%.
· La Pampas, Argentina – Health Ministry compared over 2,000 patients they treated early with ivermectin to over 12,000 without treatment and found that in patients over 40, rates of ICU admission and death both fell by 40%.
· Peru – A nationwide mass-distribution program called “Mega-Operación Tayta” (MOT), initiated at various times across 25 states of Peru in May 2020, led to a 74% drop in regional excess deaths within a month, with each drop beginning 11 days after each MOT region’s varied start times
· The Health Ministry of Sultan Kudarat in the Phillipines launched an ivermectin drive and found that cases rapidly dropped by 86%. compared to nearby regions
· In Japan, the President of the Tokyo Medical Association recommended that all physicians start to use ivermectin as early treatment during their summer surge. They are now recording the lowest rate of COVID hospitalization in the pandemic.
· 23 countries (39 including NGO’s) have now given either partial or full approval for use in COVID, which encompasses 25% of the world’s population.

https://pierrekory.substack.com/p/m...utjw&utm_campaign=post&utm_medium=web